Dr. Salwa Rhazouani, MD

Dr. Rhazouani practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Rhazouani's NPI, 1518259126, was assigned on May 15, 2011. Dr. Rhazouani graduated from Hassan II University Faculty of Medicine in 2002. Dr. Rhazouani holds Florida license ME123051.

Dr. Rhazouani's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Rhazouani's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Rhazouani is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Rhazouani to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rhazouani practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Rhazouani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rhazouani is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rhazouani's licenses on file in 6 states: Florida, California, New York, Texas, Missouri and Pennsylvania.

Dmand AI lists chronic kidney disease and electrolyte disorders among the conditions Dr. Rhazouani treats.

CMS data shows 735 Medicare services from Dr. Rhazouani across 5 procedure codes in 2024, for 204 Medicare patients. Medicare paid $76,375 for them.

CMS counts 204 Medicare patients who saw Dr. Rhazouani in 2024. The largest group is under 65, with 107 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 5.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rhazouani's median patient age at 57, with 37% women.

In 2024, Dr. Rhazouani wrote 249 Medicare Part D claims for 73 patients. 89% of them were for generic drugs. CMS names the drug for 107 of them, across 6 drugs with 11 or more claims each, at $3,902 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Rhazouani for performance year 2024, reported through an alternative payment model (APM). Dr. Rhazouani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rhazouani as offering telehealth.

Dmand AI links 2 papers to Dr. Rhazouani, published from 2014 to 2015. Dr. Rhazouani's most frequent co-authors are George Nicholas Coritsidis, MD and Suganda Phalakornkul, MD.

CMS Open Payments shows 16 general payments to Dr. Rhazouani from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $474.

Dr. Rhazouani graduated from Hassan II University Faculty of Medicine in 2002.

Dr. Rhazouani is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.